World News1 min read

Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scripts

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Therapeutics, brings scientific expertise and deal-making skills. She is poised to lead Biocon into its next growth phase. T…

T
The News Flicker
Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scripts

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Therapeutics, brings scientific expertise and deal-making skills. She is poised to lead Biocon into its next growth phase. T…

When Kiran Mazumdar-Shaw began laying out a succession plan for Biocon, one name quietly moved into focus: Claire Mazumdar.Little known outside global biotech circles until recently, Claire Mazumdar …

Originally published by The Times of India. Read the full article →

More from World News